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Battling Addiction
The University of Dayton Research Institute has won a
$10,000 Ohio Opioid Technology Challenge award for a
program that will teach people with opioid addictions
how to reduce their cravings by regaining control of
their brains.
UDRI software engineer Kelly Cashion, who wrote the winning proposal
and will lead the program, will develop and use a system of
neurofeedback therapy designed to help people "recover control of
their minds and bodies and accelerate the path to recovery," Cashion
said.
Cashion's was one of five winning proposals — two from Ohio, two
from Massachusetts and one from Utah — selected for funding by the
Ohio Third Frontier from entries submitted by researchers, service
providers and other individuals and organizations from nine countries.
The Ohio Opioid Technology Challenge was developed to help
engender solutions to the nation's growing opioid addiction crisis,
which has hit the Midwest particularly hard. In 2016, Ohio was second
only to West Virginia for the number of overdose deaths related to
opioids, according to the Centers for Disease Control.
Opioids — heroin, fentanyl and other natural and synthetic opiates —
are highly addictive, and the 90- percent relapse rate is as much as
double that associated with other addictions, according to the National
Institute on Drug Abuse. Opioid use becomes abuse — and ultimately
addiction — by shutting down the brain's ability to naturally release
dopamine and endorphins, so that the absence of opioids creates
feelings of intense anxiety and other severe symptoms of withdrawal.
Those symptoms will continue long after a person who is addicted
stops using the drugs, which contributes to the high relapse rate,
Cashion said.
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"When a person initially consumes opioids, the experience creates a
sense of euphoria caused by a release of chemicals in the brain. The
pathways in the brain that are part of that experience grow stronger —
forging an addiction — while other pathways grow weaker," she said.
"Over time, use of the drugs stops creating positive feelings, and their
absence creates painful symptoms of withdrawal, so that a person
with an addiction needs to use the drugs just to achieve a sense of
normalcy.
"Using neurofeedback, we’ll work with our volunteers to help them
learn to regulate activity in the part of their brain associated with
cravings and rewire some of those pathways, allowing them to reduce
their cravings and experience a more ‘normal’ state even without
opioids."
Neurofeedback is a type of biofeedback where sensors are used in
conjunction with a brainwave monitoring method, such as
electroencephalography (EEG), to help the wearer see his or her brain's
electrical activity in real time. The sensors — typically noninvasive and
attached to the scalp in the form of a wireless headset or a more
traditional "shower cap" style with wires — also let the wearer see if
and when certain behaviors alter their brain’s electrical activity.
In her program, Cashion will show volunteers a graphics display —
which she likened to a simple video game — on a computer monitor.
By giving the volunteers tasks that require a shift in focus or other
interaction with the game, they will see which activities most positively
impact the signals associated with cravings. After a series of training
sessions, volunteers will have learned the tasks they will need to
perform to reduce cravings, even without use of the technology.
Cashion said neurofeedback is showing promise in the treatment of
nicotine addiction, depression, chronic pain, post-traumatic stress
syndrome and other physiological disorders.
"We'll build on that body of research and transfer known protocols to
the domain of opioid addiction treatment," she said.
Cashion said neurofeedback is not meant to be a substitute for, but a
supplement to, current addiction therapies, which include medication
assisted treatment and behavioral counseling.
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"Current treatments are not always sufficient, and medication is not
always sufficiently available because of the demand on treatment
centers. Even when it is, some patients reject 'step-down' medications,
such as methadone, because they view it as replacing one addiction
with another. For those patients, neurofeedback can be another
avenue for recovery," she said.
For patients who are transitioning to recovery with the use of
medication, neurofeedback can provide additional insight into the
changes enabled by the medication, Cashion added.
At the outset of her program, Cashion will work with health care
professionals and other experts to help establish a baseline of
neurological signals and identify which signals are associated with
cravings. She'll work with other researchers in UDRI's software systems
group to use mathematical algorithms to map the 2-dimensional
baseline signal imagery to a 3-dimensional map of the brain.
"From there we'll be able to tell which parts of the brain the signals are
coming from," she said.
When she is ready to begin testing, Cashion will work with health care
professionals and agencies which serve people with opioid addictions
to help identify potential volunteers. As the program progresses,
Cashion will continue to consult with technology experts within UDRI
and external medical specialists to validate results and make program
adjustments as necessary.
"Ultimately our goal is to develop and demonstrate a neurofeedback
system that uses off-the-shelf hardware along with software
developed here at the University of Dayton Research Institute, then
work with local medical technology companies to commercialize the
product and make it available to treatment centers," Cashion said.
For media interviews, contact Pamela Gregg at
pamela.gregg@udri.udayton.edu or 937-229-3268.
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